Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy: A Randomized, Placebo Controlled Study

NCT07810504 is registered in ClinicalTrials.gov with K. Kay Durairaj, MD, FACS, A Medical Corporation as lead sponsor.

NCT NCT07810504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07810504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy: A Randomized, Placebo Controlled Study
Lead sponsor
K. Kay Durairaj, MD, FACS, A Medical Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2026
Completion date
January 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenic alopecia, female pattern hair loss, hair loss